Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News
  • Small Cap

Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?

By Vandana Singh
October 3, 9:03 AM
Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global Inc (NASDAQ: PNT) at $12.50 per share in cash, an aggregate of 

LLY

Read More
1 minute read
  • Contracts
  • Equities
  • Large Cap
  • Markets
  • News

General Dynamics Bags $218M Contract To Expand Artillery Production

By Lekha Gupta
October 3, 8:53 AM
General Dynamics Corporation (NYSE: GD) business unit, General Dynamics Ordnance and Tactical Systems (OTS), won an initial task contract worth $218 million for

GD

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Novo Nordisk Weight Loss Drug Patent Battle Against Viatris – Emerges As Winner

By Vandana Singh
October 3, 8:32 AM
Novo Nordisk A/S (NYSE: NVO) successfully defended two pivotal patent claims linked to the main ingredient in its popular weight-loss and diabetes drugs, 

NVO

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Pharma Giants Sanofi, Johnson & Johnson Join Forces To Develop E.coli Vaccine

By Vandana Singh
October 3, 8:25 AM
Sanofi SA (NASDAQ: SNY) struck a deal with Janssen Pharmaceuticals, a unit of Johnson & Johnson (NYSE: JNJ), to develop and commercialize the vaccine candidate for extraintestinal&nb

JNJ

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug

By Vandana Singh
October 3, 8:18 AM
AstraZeneca Plc (NASDAQ: AZN) has 

AZN

Read More
2 minute read
  • Contracts
  • Equities
  • Large Cap
  • Markets
  • News

Pushing Boundaries: Occidental & ADNOC Begin Preliminary Engineering Study For Direct Air Capture Facility In The UAE

By Lekha Gupta
October 3, 7:34 AM
Occidental Petroleum Corp's (NYSE: OXY) subsidiary 1PointFive inked a deal with ADNOC to start a jointly funded preliminary engineering study for a 1 million tonne-per-year 

OXY

Read More
2 minute read
  • Economics
  • ETFs
  • Federal Reserve
  • Large Cap
  • Sector ETFs
  • Tech
  • Top Stories

Fed Vice Chair Discusses Rate Hike Endgame, Sees Threat Of AI Disrupting Job Landscape

By Piero Cingari
October 2, 4:02 PM
Federal Reserve Vice Chair Michael Barr discusses the future of interest rates and the transformative potential of Generative AI in our economy. Read more here

ADBE

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Downgrades
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas

This Toast Analyst Sees Surge In GLP-1 Drugs & More Spoiling Long Term Growth Prospects

By Lekha Gupta
October 2, 2:55 PM
Mizuho Securities analyst Dan Dolev downgraded Toast Inc (NYSE: TOST), a digital technology platform built for restaurants, to Neutral from Buy and lowered the 

TOST

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • News
  • Tech

Walgreens Ends Partnership with Microsoft-Backed Cooler Screens Amidst Technical Failures

By Vandana Singh
October 2, 2:30 PM
A partnership gone sour marks the end of a technological endeavor between Walgreens Boots Alliance Inc (NASDAQ: WBA) and Cooler Screens, a vendor specializing in digital advertising screens. 

CVS

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

ONEOK Standing Tall Among Large Peers, Analyst Upgrades Stock

By Lekha Gupta
October 2, 2:28 PM
Scotiabank analyst Tristan J.

OKE

Posts pagination

Previous 1 … 200 201 202 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service